Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Benefit assessment of HPV test in primary screening for cervical cancer: Final report; Commission S10-01. November 28, 2011. (IQWiG reports; Volume 106).
Krebsinformationsdienst (KID), Deutsches Krebsforschungszentrum (DKFZ). Gebärmutterhalskrebs: Das Zervixkarzinom. March 26, 2015.
McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect 2006; 82(2): 169-174.
National Cancer Institute, National Intitutes of Health (NIH). HPV and Cancer. February 19, 2015.
Signorelli C, Odone A, Ciorba V, Cella P, Audisio RA, Lombardi A et al. Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence. Epidemiol Infect 2017; 145(10): 1962-1982.
World Health Organization (WHO). Comprehensive cervical cancer control: a guide to essential practice. Second edition. Genf: WHO Press; 2014.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.